A line graph illustrates that the proportion of reliable websites decreased and commercial advertisements increased as the search result ranks decreased. by Xi Zhu (551361)

Predator phylogenetic diversity decreases predation rate via antagonistic interactions by Andrew MacDonald (421949)

The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis by Jian Xiao (253329)

Subjects:

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…<p><b>A,B:</b> Gene knockdown of EZH2 and SUZ12 was confirmed by qPCR. …”

Anti-retroviral lectins decrease recovery of <i>Tritrichomonas</i> in a mouse vaginal model. by Aparajita Chatterjee (243431)

“…<p>Recovery of <i>Tritrichomonas</i> after two days in the vagina of mice shows a modest but statistically significant decrease by co-infection with cyanovirin-N (63% decrease), griffithsin (70% decrease), or galectin-1 (51% decrease). …”

MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

“…<p>(<b>A</b>) PC12 cells were transfected with pMT2 or pMT2-FLAG-MK-STYX-FLAG. 24 hr post-transfection cells were stimulated with 100 ng/ml NGF, and lysed at the indicated time points. …”

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Knocking down of TRIM59 decreased the expression of cell cycle proteins. by Weihua Zhan (830500)

Table 1_Effect of decreased suspended sediment content on chlorophyll-a in Dongting Lake, China.docx by Le Zhang (88249)

Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

Subjects:

TEM images of (a) amlodipine (b) hydrochlorothiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

Subjects:

Rapamycin treatment significantly decreases induction of lytic KSHV proteins. by Lisa A. Nichols (357612)

FT-IR spectra of (a) amlodipine (b) hydrochlorohiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

Subjects:

PK profile of: (a) The developed NanoFDC and (b) Combination of the free candidate drugs. by Anjuman Arora (750291)

Subjects:

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

“…<p></p><p>Abstract Purpose: To demonstrate the efficacy of 0.025% atropine eyedrops in myopic children in Brazil for decreasing myopia progression Methods: This was a prospective study with 60 children from Hospital Geral Universitário and Oftalmocenter Santa Rosa in Cuiabá, MT, Brazil, aged between 6 to 12 years, with spherical equivalent refractive error of -1.00 to -6.00 diopters (D) and astigmatism of -1.00 D or smaller. …”

Binding sites decrease the barrier to folding in hisactophilin. by Shachi Gosavi (160132)

<i>In-vitro</i> drug release profiles of (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

Subjects:

Decreased number of anastomoses in BCAS-treated mice. by Jill M. Roberts (4760685)

PK profiles of the developed nanoparticles vs. free drugs in rats (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

Subjects:

Geographical distribution of anemia among children 6–59 months. by Samnang Um (14990562)

Subjects: